A controversial nominee for FDA commissioner faced sharp scrutiny during a Senate confirmation hearing, where lawmakers pressed on divisive issues like vaccines and abortion. While the session highlighted key concerns for lawmakers, the nominee largely avoided direct answers, leaving many questions about her stance on major health policy priorities unaddressed. The hearing underscored the political tensions surrounding the role, with senators probing her potential influence over public health decisions. Details on her specific positions remained elusive, raising questions about how she might approach leadership of the agency.
Dr. Heidi Overton, President Trump’s pick to lead the Food and Drug Administration (FDA), walked a fine line Thursday on vaccines and abortion, largely dodging difficult questions from senators. The confirmation hearing in the Senate Health, Education, Labor and Pensions Committee shed light on the priorities of lawmakers but offered little about Overton’s views and...
